pH-Responsive Nanocarriers in Cancer Therapy

192Citations
Citations of this article
231Readers
Mendeley users who have this article in their library.

Abstract

A number of promising nano-sized particles (nanoparticles) have been developed to conquer the limitations of conventional chemotherapy. One of the most promising methods is stimuli-responsive nanoparticles because they enable the safe delivery of the drugs while controlling their release at the tumor sites. Different intrinsic and extrinsic stimuli can be used to trigger drug release such as temperature, redox, ultrasound, magnetic field, and pH. The intracellular pH of solid tumors is maintained below the extracellular pH. Thus, pH-sensitive nanoparticles are highly efficient in delivering drugs to tumors compared to conventional nanoparticles. This review provides a survey of the different strategies used to develop pH-sensitive nanoparticles used in cancer therapy.

Author supplied keywords

Cite

CITATION STYLE

APA

Alsawaftah, N. M., Awad, N. S., Pitt, W. G., & Husseini, G. A. (2022, March 1). pH-Responsive Nanocarriers in Cancer Therapy. Polymers. MDPI. https://doi.org/10.3390/polym14050936

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free